## Abstract Carbon‐13 and carbon‐14 labeled forms of the title compound have been prepared from the correspondingly labeled forms of 8‐chloro‐1‐methyl‐6‐phenyl‐4H‐__s__‐triazolo[4,3‐a][1,4]benzodiazepine (__3__)Alprazolam is the generic USAN name for this compound. . A modified and more convenient
A novel and efficient asymmetric synthesis of carbon-14 labeled (S,S)-2,7-di-boc-diamino[1,8-14C2]suberic acid
✍ Scribed by A. J. Villani; D. Saunders; A. Y. L. Shu; J. R. Heys
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- French
- Weight
- 112 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0022-2135
- DOI
- 10.1002/jlcr.534
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Five hundred mCi of Potassium [^14^C]cyanide at a specific activity of 51 mCi/mmol was used to diastereoselectively introduce the carbon‐14 label into 1,6‐hexanedial via a thermodynamically controlled asymmetric Strecker reaction using (R)‐(‐)‐2‐phenylglycinol as the chiral auxiliary. The expected and predominant (R,S/S,R) diastereomer (2) was separated by preparative normal phase HPLC. The chiral auxiliary was removed by oxidation with lead tetraacetate and the resulting benzylimino nitrile exhaustively hydrolyzed in hydrochloric acid to give (S,S)‐2,7‐diamino[1,8‐^14^C~2~]suberic acid (6). Subsequent acylation with di‐tert‐butyldicarbonate gave the title compound (1) with a radiochemical purity of 95.5%, a specific activity of 113 mCi/mmol, and an enantiomeric purity of 95.5% e.e. To our knowledge this is the first report of the asymmetric Strecker methodology being applied to the synthesis of a carbon‐14 labeled amino acid. Copyright © 2002 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract Here we report an efficient synthesis of ^14^C‐labeled 6‐[2‐(dimethylamino)ethyl]‐14‐(1‐ethylpropyl)‐5,6,7,8‐tetrahydroindolo‐[2,1‐__α__][2,5]benzodiazocine‐11‐carboxylic acid (1) using the Curtius rearrangement as a key step. The synthesis was initiated by converting the unlabeled aryl
## Abstract A group of radioactive 1,4‐benzodiazepine derivatives have been synthesized from glycine‐1‐^14^C. The subject compounds are labeled with carbon‐14 in the 2‐position of the 1,4‐benzodiazepine ring system.
The partial ergoline LY228729 (1) which was a potent 5HT 1A agonist has been studied clinically. Somewhat later, a related analog, (S)-di-n-propyl-(8-isoxazol-5-yl-1,2,3,4-tetrahydronaphthalen-2-yl)amine (2a) which in addition to potent 5HT 1A agonist activity was a muscarinic antagonist, was chosen